MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
Endovascular Surgery: How We Arrived Here
“…a minimal incision, limited potential for complications, short hospitalization, and rapid recovery are obvious advantages.” —Edward B. Diethrich, MD1
By John Bergan, MD, FACS, FACPh, FRCS Hon. (Eng.)
The PVSS
An update of the history and future of the Peripheral Vascular Surgery Society.
By Lewis B. Schwartz, MD, and Robert G. Scribner, MD
“Insui Shigen: When one drinks water, show respect to the person who dug the well.”
By Takao Ohki, MD, PhD, Chief Medical Editor
Percutaneous Recanalization of a Previously Ligated IVC
In selected patients, percutaneous recanalization of a surgically ligated IVC can offer an endovascular alternative to open surgery.
By Jose A. Echeverri, MD; Gregory L. Horsley, MD; Lawrence D. Buadu, MD, PhD; and John Buterbaugh, MD
Sponsored by Medtronic
Mixed Ulceration From Arterial and Venous Insufficiency: Is There an Algorithm for Treatment?
By Jon C. George, MD
Pioneering Insights: Why EVAR's History Must Guide Its Future
Aortic experts and enthusiasts convened at the 2016 VERVE Symposium in Sydney, Australia, to reflect on the first 25 years of EVAR, as well as how past lessons can streamline modern innovation.
The RESILIENT Trial Update: 6-Month Phase 1 Results
Encouraging data include no reinterventions, 100% clinical success, and no stent fractures.
By John R. Laird, Jr, MD
Lessons Learned in RESILIENT
Co-Principal Investigator John R. Laird Jr, MD, discusses the results and impact of this landmark SFA stenting trial.
Initiatives to Improve Awareness of Aortic Dissection
Advocates with Aortic Hope/Think Aorta, The John Ritter Foundation for Aortic Health, and The Aortic Dissection Collaborative for Patient-Centered Research discuss how they are raising awareness of aortic dissection through research and education.
With Carin Andersen; Ben Youdelman, MD; Ellen Hostetler; and Jake Howitt
Venous Center Accreditation
A pathway to improved quality of care.
By John Blebea, MD, MBA
Applying Simulation to Endovascular Medicine
How far has the technology progressed?
By John D. Carroll, MD
Development of a Research Agenda for IVC Filters
A preliminary report from a multidisciplinary research consensus panel.
By John A. Kaufman, MD, FSIR
Crossing CTOs With the Wildcat Catheter
Experiences using a new option for crossing difficult chronic total occlusions.
By John P. Pigott, MD
The Dare to C.A.R.E. Program
Taking vascular disease screening and community awareness to the next level.
By John D. Martin, MD; Louise Hanson, CRNP; and Jon Hupp, MD
Overview of Restenosis in Peripheral Arterial Interventions
Restenosis continues to complicate percutaneous procedures, but new treatments hold promise.
By Robert S. Dieter, MD, RVT, and John R. Laird, Jr, MD
Sponsored by Contego Medical
Smarter, Safer Carotid Stenting
A new era of technical innovation with the Neuroguard IEP® System.
With Tudor G. Jovin, MD; John R. Gaughen Jr, MD; Adnan Siddiqui, MD, PhD; and Ramesh Grandhi, MD, MS
Safety and Feasibility of Office-Based Endovascular Procedures
Lessons learned during a 6-year experience performing dialysis access and vascular interventions in an office setting.
By Krishna M. Jain, MD; John Munn, MD; Mark Rummel, MD; Dan Johnston, MD; Syed Alam, MD; and Chris Longton, RN
Sponsored by Inari Medical
Setting the New Standard for Arterial Thrombectomy
Introducing Artix, a dual aspiration and mechanical thrombectomy solution designed to address a broad spectrum of arterial thrombus cases.
With David J. Mond, MD; Christian Salinas, MD; John Parks, MD; Joshua Cockrell, MD; and John Gray, MD
Two Stick or Not Two Stick: Acute Thrombosis of Femoral-Femoral Bypass Graft Resulting in Critical Limb Ischemia
Revascularization in a patient with inflow disease of a left-to-right femoral-femoral bypass utilizing multiple access locations.
By John A. Phillips, MD
Sponsored by Zimmer Biomet
Investigating Cell Therapy to Address the Challenges of the Poor-Option Critical Limb Ischemia Patient
Experts discuss the potential for further investigation of cell therapy for the treatment of PAD/CLI
With Krishna J. Rocha-Singh, MD, FACC, FAHA; John R. Laird Jr, MD; and Mahmood Razavi, MD, FSIR